Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma

Published:2021-01-07 Issue:2 Volume:2 Page:175-206
ISSN:2688-2663
Container-title:MedComm
language:en
Short-container-title:MedComm

Author:

Zhu Qian‐Ying¹,Zhao Ge‐Xin¹,Li Yan¹,Talakatta Girish¹,Mai Hai‐Qiang¹,Le Quynh‐Thu²,Young Lawrence S.³,Zeng Mu‐Sheng¹

Affiliation:

1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Sun Yat‐sen University Cancer Center (SYSUCC) Guangzhou China

2. Department of Radiation Oncology Stanford California

3. Warwick Medical School University of Warwick Coventry United Kingdom

Funder

National Basic Research Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.32

Reference342 articles.

1. Nasopharyngeal carcinoma

2. Nasopharyngeal carcinoma

3. Epstein‐Barr virus and nasopharyngeal carcinoma;Young LS;Chin J Cancer,2014

4. Epstein–Barr virus: more than 50 years old and still providing surprises

5. Etiological factors of nasopharyngeal carcinoma

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in early detection of nasopharyngeal carcinoma;Discover Oncology;2024-08-23

2. Glutathione hybrid poly (beta-amino ester)-plasmid nanoparticles for enhancing gene delivery and biosafety;Journal of Advanced Research;2024-08

3. Revitalizing premature ovarian failure: quercetin counteracts imatinib-induced apoptosis via the PI3K/AKT signaling pathway based on network pharmacology;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-29

4. Nomograms based on multiparametric MRI radiomics integrated with clinical-radiological features for predicting the response to induction chemotherapy in nasopharyngeal carcinoma;European Journal of Radiology;2024-06

5. Potent human monoclonal antibodies targeting Epstein-Barr virus gp42 reveal vulnerable sites for virus infection;Cell Reports Medicine;2024-05